Eliquis, a brand name for apixaban, is a prescription medication used to reduce the risk of stroke in patients with atrial fibrillation (AFib). The drug was approved by the U. S. Food and drug Administration for this purpose in 2012. As a result, Eliquis has become one of the most widely prescribed anticoagulants in the United States.

Eliquis is manufactured by Bristol-Myers Squibb and Pfizer, a global biopharmaceutical company. As a long-standing leader in the field of drug regulation, the companies have teamed up to provide patients with a safe and effective medication.

The use of Eliquis in AFib patients is beneficial in a number of ways. It helps to reduce the risk of stroke by preventing the formation of blood clots in the left atrium. Additionally, it reduces the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Patients treated with Eliquis experience fewer hospitalizations and emergency department visits due to stroke-related complications.

Compared to other oral anticoagulants, Eliquis has a number of advantages. For instance, it has a low risk of drug-to-drug interactions, which can be beneficial for patients taking other medications. It also has fewer side effects and is less likely to cause bleeding in the gastrointestinal tract, compared to other oral anticoagulants.

The manufacturer of Eliquis, Bristol-Myers Squibb and Pfizer, has also recently taken steps to ensure that medication access is improved for eligible patients. Eliquis is now available through the company’s patient assistance programs, including My Lantus Savings Card and My Synvisc One Savings Plan, providing discounts to those who qualify.

By providing convenient access to Eliquis, Bristol-Myers Squibb and Pfizer are helping to ensure that AFib patients receive the highest standard of care. With increased availability comes reduced costs for patients, making Eliquis an even more attractive option and increasing access to potentially life-saving treatment.

In summary, Eliquis has a number of benefits for patients with atrial fibrillation. The drug is manufactured by a reputable company and is now cheaper and more accessible than ever. As a result, more people are able to take advantage of the life-saving treatment that Eliquis provides.